CPhI North America Debuts in May 2017

Nov 28, 2016

CPhI North America, the next iteration of the CPhI brand, is aiming to be the epicenter of pharmaceutical innovation, emerging trends, insights and community-building connections in North America. This announcement comes on the heels of its worldwide event held in October in Barcelona that reportedly broke attendance records. The show boasts more than 80 percent international attendance, but only about 1,000-1,500 Americans went to CPhI worldwide, so now they are bringing the iconic show to North America.

The inaugural event will take place on May 16-18, 2017, at the Pennsylvania Convention Center in Philadelphia, PA, adjacent to the 33rd edition of InformEx, the home of fine and specialty chemicals. Registration is now open at www.cphinorthamerica.com.

Pharmaceutical executives along with R&D, compliance, regulatory, manufacturing, QA/QC, supply chain, packaging and procurement professionals will gather to build connections, capitalize on emerging trends, further innovation and tackle industry challenges.

The launch of CPhI North America has been strategically timed to take advantage of strong industry growth and innovation while addressing the ever-increasing challenges to the future prosperity of the industry. North American pharmaceutical revenue growth is strong as the United States saw an 8.5 percent growth in 2015. As leaders in pharmaceutical innovation, North American organizations develop a staggering 36 percent of the world’s new molecular entities (NME). With incredible advancements in the understanding of how to treat a wide range of disease states, the pharmaceutical industry now has greater opportunities than ever before.

However, the industry is facing major price-control pressures, research and development (R&D) inefficiencies, a need to efficiently manufacture new types of drugs, and mounting regulatory complexity. According to show management, industry changes, challenges and opportunities call for a new event that can help the industry move forward in new ways.

“CPhI North America will provide an unrivalled opportunity to become a key stakeholder in the largest pharmaceutical market,” said Robyn Duda, CPhI North America Portfolio Director. “With the projected growth of the pharma industry in this region and the real challenges the industry is facing, there isn’t a better time to bring such an established brand to North American pharma market in 2017.”

In addition, CPhI North America will be held adjacent to InformEx, the world’s leading show for the high-value specialty chemicals marketplace. CPhI North America attendees will benefit from the tremendous specialty chemical expertise InformEx assembles, which is essential to the success of pharmaceutical product development.

CPhI North America has been designed to serve the full pharmaceutical value chain. The exhibit floor will be zoned so attendees can customize their experience. Zones include:

• iCSE: The Drug Development zone will highlight world-class CROs and other organizations serving drug developers.

• CPhI: The Manufacturing Ingredients zone will consist of active product ingredients (API) and excipient leaders.

• FDF: The Finished Drug Products zone will feature leading small and large molecule CDMO/CMOs.

• InnoPack: The Packaging zone will showcase packaging innovation.

Organizations who have already joined the event include: Abbvie, Acebright, AMRI, Ashland, Austin Chemical, BASF, Biospectra, Capsugel, Catalent, Chemo, Colorcon, DFE Pharma, FMC Corp., Millipore Sigma-Merck, Patheon, Pfizer and Softigel Procaps.

CPhI North America has forged strategic partnerships with the American Chemical Society (ACS), the largest scientific association in the world; and CBI, the industry leader in actionable life sciences content and analysis. Through these partnerships, they have created rich programming that addresses the full spectrum of the pharmaceutical value chain.

The educational programming includes a technical conference covering the most pressing topics within drug development, formulation, manufacturing and outsourcing. The program, Connect CPhI, will also include a Regulatory Town Hall and keynote sessions with the FDA and leading global regulators. The programming will extend onto the show floor where trends and insights will be shared by industry leaders.

For more information visit: www.cphinorthamerica.com.